TY - JOUR AU - Gordon, C. PY - 2014 DA - 2014// TI - Jayson, Elise C Kohn, Henry C Kitchener, Jonathan A Ledermann JO - Ovarian cancer. The Lancet VL - 384 ID - Gordon2014 ER - TY - JOUR AU - Siegel, R. AU - Ma, J. AU - Zou, Z. AU - Jemal, A. PY - 2014 DA - 2014// TI - Cancer statistics, 2014 JO - CA Cancer J Clin VL - 64 UR - https://doi.org/10.3322/caac.21208 DO - 10.3322/caac.21208 ID - Siegel2014 ER - TY - JOUR AU - Crum, C. P. AU - Herfs, M. AU - Ning, G. PY - 2013 DA - 2013// TI - Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer JO - J Pathol VL - 231 UR - https://doi.org/10.1002/path.4263 DO - 10.1002/path.4263 ID - Crum2013 ER - TY - JOUR AU - Siolas, D. AU - Hannon, G. J. PY - 2013 DA - 2013// TI - Patient-derived tumor xenografts: transforming clinical samples into mouse models JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-13-1069 DO - 10.1158/0008-5472.CAN-13-1069 ID - Siolas2013 ER - TY - JOUR AU - Rubio-Viqueira, B. AU - Hidalgo, M. PY - 2009 DA - 2009// TI - Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients JO - Clin Pharmacol Ther VL - 85 UR - https://doi.org/10.1038/clpt.2008.200 DO - 10.1038/clpt.2008.200 ID - Rubio-Viqueira2009 ER - TY - JOUR AU - Gao, H. AU - Korn, J. M. AU - Ferretti, S. PY - 2015 DA - 2015// TI - High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3954 DO - 10.1038/nm.3954 ID - Gao2015 ER - TY - JOUR AU - Talmadge, J. E. AU - Singh, R. K. AU - Fidler, I. J. AU - Raz, A. PY - 2007 DA - 2007// TI - Murine models to evaluate novel and conventional therapeutic strategies for cancer JO - Am J Pathol VL - 170 UR - https://doi.org/10.2353/ajpath.2007.060929 DO - 10.2353/ajpath.2007.060929 ID - Talmadge2007 ER - TY - JOUR AU - Hidalgo, M. AU - Amant, F. AU - Biankin, A. V. PY - 2014 DA - 2014// TI - Patient-derived xenograft models: an emerging platform for translational cancer research JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-14-0001 DO - 10.1158/2159-8290.CD-14-0001 ID - Hidalgo2014 ER - TY - STD TI - Scott CL, Mackay HJ, Haluska P, Jr. Patient-derived xenograft models in gynecologic malignancies. Am Soc Clin Oncol Educ Book. 2014;e258-266. ID - ref9 ER - TY - JOUR AU - Zhang, Q. AU - Ubago, J. AU - Li, L. PY - 2014 DA - 2014// TI - Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma JO - Cancer VL - 120 UR - https://doi.org/10.1002/cncr.28900 DO - 10.1002/cncr.28900 ID - Zhang2014 ER - TY - JOUR AU - Dong, R. AU - Liu, X. AU - Zhang, Q. PY - 2014 DA - 2014// TI - miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.2522 DO - 10.18632/oncotarget.2522 ID - Dong2014 ER - TY - JOUR AU - Xu, X. AU - Ayub, B. AU - Liu, Z. PY - 2014 DA - 2014// TI - Anti-miR182 reduces ovarian cancer burden, invasion, and metastasis: an in vivo study in orthotopic xenografts of nude mice JO - Mol Cancer Ther VL - 13 UR - https://doi.org/10.1158/1535-7163.MCT-13-0982 DO - 10.1158/1535-7163.MCT-13-0982 ID - Xu2014 ER - TY - JOUR AU - Weroha, S. J. AU - Becker, M. A. AU - Enderica-Gonzalez, S. PY - 2014 DA - 2014// TI - Tumorgrafts as in vivo surrogates for women with ovarian cancer JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2611 DO - 10.1158/1078-0432.CCR-13-2611 ID - Weroha2014 ER - TY - JOUR AU - Bapat, S. A. AU - Mali, A. M. AU - Koppikar, C. B. AU - Kurrey, N. K. PY - 2005 DA - 2005// TI - Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer JO - Cancer Res VL - 65 ID - Bapat2005 ER - TY - JOUR AU - Davy, M. AU - Mossige, J. AU - Johannessen, J. V. PY - 1977 DA - 1977// TI - Heterologous growth of human ovarian cancer. A new in vivo testing system JO - Acta Obstet Gynecol Scand VL - 56 UR - https://doi.org/10.3109/00016347709158340 DO - 10.3109/00016347709158340 ID - Davy1977 ER - TY - JOUR AU - Stratton, J. A. AU - Micha, J. P. AU - Rettenmaier, M. A. AU - Braley, P. S. AU - DiSaia, P. J. PY - 1984 DA - 1984// TI - Chemosensitivity testing of nonsolid tumors by the subrenal-capsule implant assay JO - Gynecol Oncol VL - 17 UR - https://doi.org/10.1016/0090-8258(84)90075-1 DO - 10.1016/0090-8258(84)90075-1 ID - Stratton1984 ER - TY - JOUR AU - Ward, B. G. AU - Wallace, K. AU - Shepherd, J. H. AU - Balkwill, F. R. PY - 1987 DA - 1987// TI - Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice JO - Cancer Res VL - 47 ID - Ward1987 ER - TY - JOUR AU - Fu, X. AU - Hoffman, R. M. PY - 1993 DA - 1993// TI - Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens JO - Anticancer Res VL - 13 ID - Fu1993 ER - TY - JOUR AU - Xu, Y. AU - Silver, D. F. AU - Yang, N. P. PY - 1999 DA - 1999// TI - Characterization of human ovarian carcinomas in a SCID mouse model JO - Gynecol Oncol VL - 72 UR - https://doi.org/10.1006/gyno.1998.5238 DO - 10.1006/gyno.1998.5238 ID - Xu1999 ER - TY - JOUR AU - Dobbin, Z. C. AU - Katre, A. A. AU - Steg, A. D. PY - 2014 DA - 2014// TI - Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.2373 DO - 10.18632/oncotarget.2373 ID - Dobbin2014 ER - TY - JOUR AU - Zhang, S. AU - Cui, B. AU - Lai, H. PY - 2014 DA - 2014// TI - Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy JO - Proc Natl Acad Sci U S A VL - 111 UR - https://doi.org/10.1073/pnas.1419599111 DO - 10.1073/pnas.1419599111 ID - Zhang2014 ER - TY - JOUR AU - Topp, M. D. AU - Hartley, L. AU - Cook, M. PY - 2014 DA - 2014// TI - Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts JO - Mol Oncol VL - 8 UR - https://doi.org/10.1016/j.molonc.2014.01.008 DO - 10.1016/j.molonc.2014.01.008 ID - Topp2014 ER - TY - JOUR AU - Stewart, J. M. AU - Shaw, P. A. AU - Gedye, C. AU - Bernardini, M. Q. AU - Neel, B. G. AU - Ailles, L. E. PY - 2011 DA - 2011// TI - Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1005529108 DO - 10.1073/pnas.1005529108 ID - Stewart2011 ER - TY - JOUR AU - Verschraegen, C. F. AU - Hu, W. AU - Du, Y. PY - 2003 DA - 2003// TI - Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers JO - Clin Cancer Res VL - 9 ID - Verschraegen2003 ER - TY - JOUR AU - Vidal, A. AU - Munoz, C. AU - Guillen, M. J. PY - 2012 DA - 2012// TI - Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-1513 DO - 10.1158/1078-0432.CCR-12-1513 ID - Vidal2012 ER - TY - JOUR AU - Groeneweg, J. W. AU - DiGloria, C. M. AU - Yuan, J. PY - 2014 DA - 2014// TI - Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growth JO - Front Oncol VL - 4 UR - https://doi.org/10.3389/fonc.2014.00171 DO - 10.3389/fonc.2014.00171 ID - Groeneweg2014 ER - TY - JOUR AU - McCann, C. K. AU - Growdon, W. B. AU - Kulkarni-Datar, K. PY - 2011 DA - 2011// TI - Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0028077 DO - 10.1371/journal.pone.0028077 ID - McCann2011 ER - TY - JOUR AU - Ghamande, S. AU - Hylander, B. L. AU - Oflazoglu, E. AU - Lele, S. AU - Fanslow, W. AU - Repasky, E. A. PY - 2001 DA - 2001// TI - Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin JO - Cancer Res VL - 61 ID - Ghamande2001 ER - TY - JOUR AU - Stany, M. P. AU - Vathipadiekal, V. AU - Ozbun, L. PY - 2011 DA - 2011// TI - Identification of novel therapeutic targets in microdissected clear cell ovarian cancers JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0021121 DO - 10.1371/journal.pone.0021121 ID - Stany2011 ER - TY - JOUR AU - Lee, J. -. W. AU - Ryu, J. i. -. Y. o. o. n. AU - Yoon, G. AU - Jeon, H. -. K. AU - Cho, Y. -. J. AU - Choi, J. -. J. AU - Song, S. Y. AU - Do, I. n. -. G. u. AU - Lee, Y. -. Y. AU - Kim, T. -. J. AU - Choi, C. H. AU - Kim, B. -. G. AU - Bae, D. -. S. PY - 2015 DA - 2015// TI - Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer JO - International Journal of Cancer VL - 137 UR - https://doi.org/10.1002/ijc.29362 DO - 10.1002/ijc.29362 ID - Lee2015 ER - TY - JOUR AU - Lee, C. H. AU - Xue, H. AU - Sutcliffe, M. PY - 2005 DA - 2005// TI - Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models JO - Gynecol Oncol VL - 96 UR - https://doi.org/10.1016/j.ygyno.2004.09.025 DO - 10.1016/j.ygyno.2004.09.025 ID - Lee2005 ER - TY - JOUR AU - Malaney, P. AU - Nicosia, S. V. AU - Dave, V. PY - 2014 DA - 2014// TI - One mouse, one patient paradigm: new avatars of personalized cancer therapy JO - Cancer Lett VL - 344 UR - https://doi.org/10.1016/j.canlet.2013.10.010 DO - 10.1016/j.canlet.2013.10.010 ID - Malaney2014 ER - TY - JOUR AU - Kleine, W. PY - 1986 DA - 1986// TI - Prognostic significance of growth characteristics of xenotransplanted ovarian carcinomas into nude mice JO - Gynecol Oncol VL - 25 UR - https://doi.org/10.1016/0090-8258(86)90066-1 DO - 10.1016/0090-8258(86)90066-1 ID - Kleine1986 ER - TY - JOUR AU - Bankert, R. B. AU - Balu-Iyer, S. V. AU - Odunsi, K. PY - 2011 DA - 2011// TI - Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0024420 DO - 10.1371/journal.pone.0024420 ID - Bankert2011 ER - TY - JOUR AU - Ricci, F. AU - Bizzaro, F. AU - Cesca, M. PY - 2014 DA - 2014// TI - Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-0274 DO - 10.1158/0008-5472.CAN-14-0274 ID - Ricci2014 ER - TY - JOUR AU - Press, J. Z. AU - Kenyon, J. A. AU - Xue, H. PY - 2008 DA - 2008// TI - Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy JO - Gynecol Oncol VL - 110 UR - https://doi.org/10.1016/j.ygyno.2008.03.011 DO - 10.1016/j.ygyno.2008.03.011 ID - Press2008 ER - TY - JOUR AU - Elkas, J. C. AU - Baldwin, R. L. AU - Pegram, M. AU - Tseng, Y. AU - Slamon, D. AU - Karlan, B. Y. PY - 2002 DA - 2002// TI - A human ovarian carcinoma murine xenograft model useful for preclinical trials JO - Gynecol Oncol VL - 87 UR - https://doi.org/10.1006/gyno.2002.6819 DO - 10.1006/gyno.2002.6819 ID - Elkas2002 ER - TY - JOUR AU - Massazza, G. AU - Tomasoni, A. AU - Lucchini, V. PY - 1989 DA - 1989// TI - Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy JO - Int J Cancer VL - 44 UR - https://doi.org/10.1002/ijc.2910440320 DO - 10.1002/ijc.2910440320 ID - Massazza1989 ER - TY - JOUR AU - Curley, M. D. AU - Therrien, V. A. AU - Cummings, C. L. PY - 2009 DA - 2009// TI - CD133 expression defines a tumor initiating cell population in primary human ovarian cancer JO - Stem Cells VL - 27 ID - Curley2009 ER - TY - JOUR AU - Kolfschoten, G. M. AU - Pinedo, H. M. AU - Scheffer, P. G. AU - Schluper, H. M. AU - Erkelens, C. A. AU - Boven, E. PY - 2000 DA - 2000// TI - Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system JO - Gynecol Oncol VL - 76 UR - https://doi.org/10.1006/gyno.1999.5689 DO - 10.1006/gyno.1999.5689 ID - Kolfschoten2000 ER - TY - JOUR AU - Kortmann, U. AU - McAlpine, J. N. AU - Xue, H. PY - 2011 DA - 2011// TI - Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-1382 DO - 10.1158/1078-0432.CCR-10-1382 ID - Kortmann2011 ER - TY - JOUR AU - Scott, C. L. AU - Becker, M. A. AU - Haluska, P. AU - Samimi, G. PY - 2013 DA - 2013// TI - Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment JO - Front Oncol VL - 3 UR - https://doi.org/10.3389/fonc.2013.00295 DO - 10.3389/fonc.2013.00295 ID - Scott2013 ER -